Lilly Just Took Major Steps Forward in Obesity Drug Market
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
Find out what would be a good investment for young adults and kickstart your investment journey with confidence.
21,907 articlesTwo bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
In late 2025, Berkshire added 8 million shares to a major energy producer, lifting its portfolio weight. This move po...
A single stock is riding two powerful trends—aviation and AI-driven data centers. This article breaks down why 2026 i...
As the Fed's path becomes less predictable, investors weigh how many rate cuts to expect in 2026. This guide breaks d...
SLV has surged about 132% over the past year as inflation fears persist. But the 0.50% annual fee and a 28% tax on co...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
SoftBank announces a sweeping €75 billion plan to build up to 5 GW of AI data center capacity in France, with an init...
A hot new Snowflake product could change how companies store and analyze data. This guide breaks down what it means f...
A wave of consolidation in homebuilding is driven by scale and access to the foreign capital market, reshaping how de...
JPMorgan Chase moves to a two-person succession test by naming Doug Petno and Troy Rohrbaugh co-presidents, laying th...
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...